Clinical Trials Directory

Trials / Unknown

UnknownNCT02087345

Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion

Gastro-oesophageal Reflux in Oligosymptomatic Patients With Dental Erosion: a Longitudinal Study With pH-impedance Monitoring

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Brain-Gut Research Group · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dental erosions, the chemical dissolution of enamel without bacterial involvement, are considered to be an established complication of gastroesophageal reflux disease (GERD) by the Montreal global consensus statement. Given the high prevalence of dental erosions and the absence of any pH-impedance data or medical management guidelines for GERD-associated dental erosions, reflux characteristics will be characterized using questionnaires, endoscopy and esophageal pH-impedance testing, in successive patients dental erosions referred by dentists for evaluation of GERD. For assessment of the role of additional factors besides H+ activity in the refluxate, a sample of gastric juice will be aspirated during endoscopy and frozen for analysis of pepsin and other proteases. Prognostic factors for progression of dental erosions will be determined by repeating the evaluation after chronic dosing with esomeprazole 20mg twice-daily, which is prescribed to all patients.

Conditions

Timeline

Start date
2018-12-15
Primary completion
2022-12-01
Completion
2023-06-01
First posted
2014-03-14
Last updated
2021-03-30

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02087345. Inclusion in this directory is not an endorsement.